Fig. 3.
Cumulative incidence of delayed complications dependent on acute and chronic GVHD. (A) Skin disease; (B) cataracts; (C) lung disease; (D) bone and joint disease; (E) posttransplant malignancy; (F) depression. For any patient, only the first event was considered. While only 2-year survivors were included in the analysis, the onset of a given complication could have been before the 2-year mark. A, acute GVHD; C, chronic GVHD; “+”, present; “—”, absent